255 related articles for article (PubMed ID: 30853323)
1. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
Ventéjou S; Bagny K; Waldmeyer J; Cartault F; Machet L; Osdoit S
Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
[TBL] [Abstract][Full Text] [Related]
2. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells.
Takebe H; Nishigori C; Tatsumi K
J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human papillomavirus in skin tumors from repair deficient xeroderma pigmentosum patients.
Luron L; Avril MF; Sarasin A; Daya-Grosjean L
Cancer Lett; 2007 Jun; 250(2):213-9. PubMed ID: 17126994
[TBL] [Abstract][Full Text] [Related]
5. Dermoscopy of skin lesions in two patients with xeroderma pigmentosum.
Malvehy J; Puig S; Martí-Laborda RM
Br J Dermatol; 2005 Feb; 152(2):271-8. PubMed ID: 15727638
[TBL] [Abstract][Full Text] [Related]
6. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
Kraemer KH; Lee MM; Andrews AD; Lambert WC
Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care.
Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T
Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.
Alwatban L; Binamer Y
Ann Saudi Med; 2017; 37(3):240-244. PubMed ID: 28578364
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical prognostic criteria in xeroderma pigmentosum.
Karakok M; Turkmen A; Bekerecioglu M; Koçer NE
Int J Dermatol; 2010 Nov; 49(11):1266-71. PubMed ID: 21038547
[TBL] [Abstract][Full Text] [Related]
10. Xeroderma pigmentosum clinical practice guidelines.
Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C;
J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907
[TBL] [Abstract][Full Text] [Related]
11. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum.
Kraemer KH; Lee MM; Scotto J
Carcinogenesis; 1984 Apr; 5(4):511-4. PubMed ID: 6705149
[TBL] [Abstract][Full Text] [Related]
12. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
13. [Xeroderma pigmentosum (XP) : A genetic disease sheds light on UV-induced skin cancer].
Emmert B; Hallier E; Schön MP; Emmert S
Hautarzt; 2011 Feb; 62(2):91-7. PubMed ID: 21243329
[TBL] [Abstract][Full Text] [Related]
14. [Xeroderma pigmentosum: children of the moon].
Herouy Y; Krutmann J; Norgauer J; Schöpf E
J Dtsch Dermatol Ges; 2003 Mar; 1(3):191-8. PubMed ID: 16285494
[TBL] [Abstract][Full Text] [Related]
15. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients.
Couvé-Privat S; Bouadjar B; Avril MF; Sarasin A; Daya-Grosjean L
Cancer Res; 2002 Dec; 62(24):7186-9. PubMed ID: 12499255
[TBL] [Abstract][Full Text] [Related]
16. Oral mucosa involvement in pediatric patients with xeroderma pigmentosum: a comprehensive review.
Baskurt D; Vural S; Ertekin SS; Baykal C
Int J Dermatol; 2024 Jan; 63(1):59-72. PubMed ID: 37964400
[TBL] [Abstract][Full Text] [Related]
17. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.
Bradford PT; Goldstein AM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Pike KM; Raziuddin A; Plona TM; DiGiovanna JJ; Tucker MA; Kraemer KH
J Med Genet; 2011 Mar; 48(3):168-76. PubMed ID: 21097776
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum and skin cancer.
Daya-Grosjean L
Adv Exp Med Biol; 2008; 637():19-27. PubMed ID: 19181107
[TBL] [Abstract][Full Text] [Related]
19. Skin tumors in xeroderma pigmentosum: Evaluation of a large series and a literature review.
Baykal C; Atcı T; Yılmaz Z; Büyükbabani N
J Cutan Pathol; 2021 Jul; 48(7):884-895. PubMed ID: 33569789
[TBL] [Abstract][Full Text] [Related]
20. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
